Indian delegation was led by NCB Director General Anurag Garg, while the US side was headed by Debbie Seguin, acting deputy director of the Office of National Drug Control Policy
Opening the discussions, NCB Director General Garg spotlighted the India Vision Roadmap 2026–2029—formulated under the guidance of Prime Minister Narendra Modi and Home Minister Amit Shah. Referencing President Trump’s 2026 National Drug Control Strategy, Carter noted that countering these adaptive networks requires an equally targeted international response to secure commercial supply chains against chemical and pharmaceutical diversion. Underscoring the shared threat landscape, ONDCP Director and U.S. Drug Czar Sara Carter stressed that bilateral cooperation is vital to neutralizing transnational cartels that now operate like sophisticated multinational logistics enterprises.
Amplifying the operational impact on the ground, U.S. Ambassador to India Sergio Gor pointed to tangible results delivered by the partnership. Gor stated that both countries are actively choking off illicit precursor chemicals and dismantling cartels through high-trust, rapid law enforcement coordination that safeguards families in both nations.